Market Analytics III-21Table 53: The US Recent Past, Current & Future Analysis forPediatric Drugs and Vaccines by Therapeutic Class -Pediatric Vaccines, Pediatric Hormones, Allergy &Respiratory Drugs, Anti-infective
Drugs, CNS Drugs and OtherPediatric Drugs Market Independently Analyzed with AnnualSales in US$ Million for Years 2013 through 2020 (includescorresponding Graph/Chart) III-21
The oral solid anti-infective
market in the US represents approximately US$10.
Modification of medical device surface without anti-infective
The company's focus is toward anti-infective
drug development with three product candidates in human clinical development, multiple product opportunities in preclinical development, and several early-stage technologies in various stages of research and evaluation.
The report includes a compilation of current active projects in research and development of anti-infective
The report includes a compilation of product portfolios and current active projects in research and development of anti-infective
antibodies and immunoglobulins.
The Company is focused on the development of novel anti-infective
drugs for the treatment of lung infections and other surface infections.
Developers and Marketers for Anti-infective
and Antimicrobial Rx Drugs/Biologics
company, announces the launch of its Anti-Infective
Pharmaceuticals Market in India 2011 report.
a pharmaceutical company focused on developing and commercializing novel anti-infective
products, today announced that MiddleBrook President and CEO John Thievon will be presenting at the Rodman & Renshaw 10th Annual Healthcare Conference at the New York Palace Hotel in New York City on Nov.
Garamycin Ophthalmic Solution, a broad spectrum anti-infective
, is indicated for the treatment of ocular bacterial infections such as conjunctivitis, keratitis and blepharitis.
Replidyne is a biopharmaceutical company focused on discovering, developing, in-licensing and commercializing innovative anti-infective
This report analyzes the anti-infective
drugs market and highlights the existing and developing anti-infectives
used to ameliorate infectious diseases' afflictions on humankind.
com/research/6fee14/competitor_analysi) has announced the addition of the "Competitor Analysis: Anti-Infective
Antibodies" report to their offering.
This report provides a detailed description of the current infectious diseases drugs market and highlights the existing and developing anti-infective
agents used to ameloriate diseases' afflications on humankind.